AbbVie Inc. targets $38B in Skyrizi and Rinvoq sales by 2030, a 3% dividend yield, and 7.7% EPS growth via acquisitions.

Shield’s FDA-approved blood test drives cancer screening growth, pricing power, and cash-flow upside. Click for this GH ...

As Tata Steel announces its Q3 earnings on Friday, all eyes will be on the turnaround in its UK business, European carbon tax ...

The crypto exchange has appointed a new CEO to succeed Caroline Bowler and a new CCO amid bitcoin’s slump to pre-Trump re-election lows.

Along with government agencies local non-profits are a lifeline for so many affected by the winter storm. One key group ...

A chemical specialty products supplier has signed one of the largest office leases in Horsham in recent years.

BTC Markets has named Lucas Dobbins as chief executive and board director, while Paul Stonham has become chief commercial officer.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

To ensure you get a post that’ll definitely work with your bike, Ascend has a sizing tool feature on its website. It simply ...

LUND, SE / ACCESS Newswire / January 23, 2026 / Cantargia AB (Publ) (STO:CANTA) today reported that the first patient has been dosed in a Phase 1b/2 clinical trial investigating nadunolimab in ...

REDWOOD CITY, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today ...

The findings of the latest CRDC annual Grower Survey were released in October, with a new section focused on alternative ...